Is Genincode PLC halal to invest in?

According to Musaffa's Shariah screening methodology, Genincode PLC (GENI.L) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Genincode PLC a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genincode PLC using these criteria to determine its compliance status.

Can Muslims buy shares of Genincode PLC?

Muslim investors may consider investing in Genincode PLC if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Genincode PLC classified as HALAL?

Musaffa determines the Shariah status of Genincode PLC by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Genincode PLC updated?

The Shariah compliance status of Genincode PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Genincode PLC become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Genincode PLC?

You can check the latest Shariah compliance status of Genincode PLC on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Genincode PLC GENI.L

GBX1.13

Last Updated: May 15, 12:00 AM·LSE

GENI.L Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 23, 2026

Report Source: 2025 2nd Quarter Report

Analyst's Ratings for Genincode PLC (GENI.L)

Based on 5 analysts giving stock ratings to Genincode PLC in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Genincode PLC. Stock Analysis GENI.L

United Kingdom Health Care Nano Cap Report: Q2, 2025

GENinCode Plc engages in the genetic risk assessment of cardiovascular disease. The firm operates business units in the United Kingdom, Europe through GENinCode S.L.U, and in the United States through GENinCode U.S. Inc. Its predictive technology provides patients and physicians with preventive care and treatment strategies. GENinCode invitro-diagnostic molecular tests combine clinical algorithms and AI bioinformatics to advance patient risk assessment to prevent the onset of cardiovascular disease and ovarian cancer. Its testing products include CARDIO inCode Score, LIPID inCode, SUDD inCode, THROMBO inCode, and ROCA Test. Its SITAB is an online Web portal, which provides health care practitioners with a systemized approach to request, record, process and report their clinical and genetic test results. Its CARDIO inCode Score is a genetic test for the evaluation of the coronary genetic load based on a polygenic risk score.

Key Statistics of Genincode PLC (GENI.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX1.05GBX1.13

Today's Open

GBX1.13

Volume

4.55M

P/E Ratio (TTM)

52 Week Range

GBX0.98GBX5.00

Market Cap

922.48M

Avg. Volume

4.33M

Dividend Yield

Financial Metrics & Statements of Genincode PLC (GENI.L)

FAQ's for Genincode PLC (GENI.L)

According to Musaffa’s Shariah screening methodology, Genincode PLC (GENI.L) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.